822 related articles for article (PubMed ID: 10977776)
1. Angiotensin II and its receptors in the diabetic kidney.
Burns KD
Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
[TBL] [Abstract][Full Text] [Related]
2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
3. Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
Hollenberg NK
Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S18-23. PubMed ID: 10986155
[TBL] [Abstract][Full Text] [Related]
4. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
Zimpelmann J; Kumar D; Levine DZ; Wehbi G; Imig JD; Navar LG; Burns KD
Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066
[TBL] [Abstract][Full Text] [Related]
5. Role of angiotensin II in diabetic nephropathy.
Kennefick TM; Anderson S
Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
[TBL] [Abstract][Full Text] [Related]
6. Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors.
Wehbi GJ; Zimpelmann J; Carey RM; Levine DZ; Burns KD
Am J Physiol Renal Physiol; 2001 Feb; 280(2):F254-65. PubMed ID: 11208601
[TBL] [Abstract][Full Text] [Related]
7. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.
Huang Q; Guo Y; Zeng H; Xie W; Yan H; Ding H
Endocr Res; 2011; 36(3):93-100. PubMed ID: 21314328
[TBL] [Abstract][Full Text] [Related]
8. Activation of a local renin angiotensin system in podocytes by glucose.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blockade in diabetic nephropathy.
Andersen S
Dan Med Bull; 2004 Aug; 51(3):274-94. PubMed ID: 16009059
[No Abstract] [Full Text] [Related]
10. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
[TBL] [Abstract][Full Text] [Related]
11. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat.
Anderson S
Miner Electrolyte Metab; 1998; 24(6):406-11. PubMed ID: 9930380
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II in diabetic nephropathy.
Leehey DJ; Singh AK; Alavi N; Singh R
Kidney Int Suppl; 2000 Sep; 77():S93-8. PubMed ID: 10997697
[TBL] [Abstract][Full Text] [Related]
13. [The renin-angiotensin-aldosterone system -- more complex as previously thought].
Wolf G
Med Klin (Munich); 2005 Aug; 100(8):471-7. PubMed ID: 16096728
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
16. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.
Wolf G; Ziyadeh FN
Am J Kidney Dis; 1997 Jan; 29(1):153-63. PubMed ID: 9002545
[TBL] [Abstract][Full Text] [Related]
17. AT(1) and AT(2) receptors in the kidney: role in disease and treatment.
Siragy HM
Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S4-9. PubMed ID: 10986153
[TBL] [Abstract][Full Text] [Related]
18. Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats.
Fan YY; Kobori H; Nakano D; Hitomi H; Mori H; Masaki T; Sun YX; Zhi N; Zhang L; Huang W; Zhu B; Li P; Nishiyama A
Horm Metab Res; 2013 May; 45(5):338-43. PubMed ID: 23322513
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
[TBL] [Abstract][Full Text] [Related]
20. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Kobori H; Nangaku M; Navar LG; Nishiyama A
Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
